CoChat

The mood stabilizer valproate activates human FGF 1 gene promoter through inhibiting HDAC and GSK‐3 activities

Kao, Chien‐Yu, Hsu, Yi‐Chao, Liu, Jen‐Wei, Lee, Don‐Ching, Chung, Yu‐Fen, Chiu, Ing‐Ming · 2013 · Journal of Neurochemistry
Cited by 37

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Valproic acid (VPA) is the primary mood‐stabilizing drug to exert neuroprotective effects and to treat bipolar disorder in clinic. Fibroblast growth factor 1 (FGF1) has been shown to regulate cell proliferation, cell division, and neurogenesis. Human FGF1 gene 1B promoter (−540 to +31)‐driven green fluorescence (F1BGFP) has been shown to recapitulate endogenous FGF1 gene expression and facilitates the isolation of neural stem/progenitor cells (NSPCs) from developing and adult mouse brains. In this study, we provide several lines of evidence to demonstrate the underlying mechanisms of VPA in activating FGF‐1B promoter activity: (i) VPA significantly increased the FGF‐1B mRNA expression and the percentage of F1BGFP(+) cells; (ii) the increase of F1BGFP expression by VPA involves changes of regulatory factor X (RFX) 1‐3 transcriptional complexes and the increase of histone H3 acetylation on the 18‐bp cis‐element of FGF‐1B promoter; (iii) treatments of other histone deacetylases (HDAC) inhibitors, sodium butyrate and trichostatin A, significantly increased the expression levels of FGF‐1B, RFX2, and RFX3 transcripts; (iv) treatments of glycogen synthase kinase 3 (GSK‐3) inhibitor, lithium, or GSK‐3 siRNAs also significantly activated FGF‐1B promoter; (v) VPA specifically enhanced neuronal differentiation in F1BGFP(+) embryonic stem cells and NSPCs rather than GFP(−) cells. This study suggested, for the first time, that VPA activates human FGF1 gene promoter through inhibiting HDAC and GSK‐3 activities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.12292

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 37

Metadata

Authors
Kao, C., Hsu, Y., Liu, J., Lee, D., Chung, Y., & Chiu, I.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2013-05-21
Volume
126
Issue
1
Pages
4-18
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1966959753
Cited by
37
References
10
FWCI
2.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The mood stabilizer valproate activates human FGF 1 gene promoter through inhibiting HDAC and GSK‐3 activities. https://app.cochat.ai/papers/10.1111/jnc.12292
The paper
Kao, C., Hsu, Y., Liu, J., Lee, D., Chung, Y., & Chiu, I. (2013). The mood stabilizer valproate activates human FGF 1 gene promoter through inhibiting HDAC and GSK‐3 activities. Journal of Neurochemistry. https://doi.org/10.1111/jnc.12292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.